The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection
Open accessAbstract
BACKGROUND: The effect of procalcitonin-guided use of antibiotics on treatment for suspected lower respiratory tract infection is unclear. METHODS: In 14 U.S. hospitals with high adherence to quality measures for the treatment of pneumonia, we provided guidance for clinicians about national clinical practice recommendations for the treatment of lower respiratory tract infections and the interpretation of procalcitonin assays. We then randomly assigned patients who presented to the emergency department with a suspected lower respiratory tract infection and for whom the treating physician was uncertain whether antibiotic therapy was indicated to one of two groups: the procalcitonin group, in which the treating clinicians were provided with real-time initial (and serial, if the patient was hospitalized) procalcitonin assay results and an antibiotic use guideline with graded recommendations based on four tiers of procalcitonin levels, or the usual-care group. We hypothesized that within 30 days after enrollment the total antibiotic-days would be lower - and the percentage of patients with adverse outcomes would not be more than 4.5 percentage points higher - in the procalcitonin group than in the usual-care group. RESULTS: A total of 1656 patients were included in the final analysis cohort (826 randomly assigned to the procalcitonin group and 830 to the usual-care group), of whom 782 (47.2%) were hospitalized and 984 (59.4%) received antibiotics within 30 days. The treating clinician received procalcitonin assay results for 792 of 826 patients (95.9%) in the procalcitonin group (median time from sample collection to assay result, 77 minutes) and for 18 of 830 patients (2.2%) in the usual-care group. In both groups, the procalcitonin-level tier was associated with the decision to prescribe antibiotics in the emergency department. There was no significant difference between the procalcitonin group and the usual-care group in antibiotic-days (mean, 4.2 and 4.3 days, respectively; difference, -0.05 day; 95% confidence interval [CI], -0.6 to 0.5; P=0.87) or the proportion of patients with adverse outcomes (11.7% [96 patients] and 13.1% [109 patients]; difference, -1.5 percentage points; 95% CI, -4.6 to 1.7; P<0.001 for noninferiority) within 30 days. CONCLUSIONS: The provision of procalcitonin assay results, along with instructions on their interpretation, to emergency department and hospital-based clinicians did not result in less use of antibiotics than did usual care among patients with suspected lower respiratory tract infection. (Funded by the National Institute of General Medical Sciences; ProACT ClinicalTrials.gov number, NCT02130986 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma
Program, P., & theDiagnosis, T. E. P. O. (1997) · Cited by 4,926
A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia
Fine, M. J., Auble, T. E., Yealy, D. M., Hanusa, B. H., Weissfeld, L. A., Singer, D. E., Coley, C. M., Marrie, T. J., & Kapoor, W. N. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701233360402 · Cited by 4,582
Self-citationKalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw353 · Cited by 3,892
Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0218pp · Cited by 3,187
Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J., Srinivasan, A., Dellit, T. H., Falck-Ytter, Y. T., Fishman, N. O., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw118 · Cited by 3,061
Piaggio, G., Elbourne, D. R., Pocock, S. J., Evans, S. J. W., Altman, D. G., & CONSORT Group, F. T. (2012) · JAMA · doi:10.1001/jama.2012.87802 · Cited by 2,428
High serum procalcitonin concentrations in patients with sepsis and infection
Assicot, M., Bohuon, C., Gendrel, D., Raymond, J., Carsin, H., & Guilbaud, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90277-n · Cited by 2,197
(2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.09.029 · Cited by 2,181
Reddel, H. K., Taylor, D. R., Bateman, E. D., Boulet, L.-P., Boushey, H. A., Busse, W. W., Casale, T. B., Chanez, P., Enright, P. L., Gibson, P. G., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-060st · Cited by 1,918
Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011
Fleming-Dutra, K. E., Hersh, A. L., Shapiro, D. J., Bartoces, M., Enns, E. A., File, T. M., Finkelstein, J. A., Gerber, J. S., Hyun, D. Y., Linder, J. A., et al. (2016) · JAMA · doi:10.1001/jama.2016.4151 · Cited by 1,740
Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., Gencay, M. M., Huber, P. R., Tamm, M., & Müller, B. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15591-8 · Cited by 1,096
Schuetz, P., Christ-Crain, M., Thomann, R., Falconnier, C., Wolbers, M., Widmer, I., Neidert, S., Fricker, T., Blum, C., Schild, U., et al. (2009) · JAMA · doi:10.1001/jama.2009.1297 · Cited by 959
Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia: A Randomized Trial
Christ-Crain, M., Stolz, D., Bingisser, R., Müller, C., Miedinger, D., Huber, P. R., Zimmerli, W., Harbarth, S., Tamm, M., & Müller, B. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200512-1922oc · Cited by 884
Morosco, G., & Kiley, J. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.09.043 · Cited by 867
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Schuetz, P., Wirz, Y., Sager, R., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007498.pub3 · Cited by 649
Antibiotic Treatment of Exacerbations of COPD
Stolz, D., Christ-Crain, M., Bingisser, R., Leuppi, J., Miedinger, D., Müller, C., Huber, P., Müller, B., & Tamm, M. (2007) · Chest · doi:10.1378/chest.06-1500 · Cited by 521
Toward an Epidemiology and Natural History of SIRS (Systemic Inflammatory Response Syndrome)
Bone, R. C. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490240060037 · Cited by 513
Antibiotic Resistance — Problems, Progress, and Prospects
Nathan, C., & Cars, O. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1408040 · Cited by 491
Ubiquitous Expression of the Calcitonin-I Gene in Multiple Tissues in Response to Sepsis1
Müller, B., White, J. C., Nylén, E. S., Snider, R. H., Becker, K. L., & Habener, J. F. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7089 · Cited by 440
Müller, B., Harbarth, S., Stolz, D., Bingisser, R., Mueller, C., Leuppi, J., Nusbaumer, C., Tamm, M., & Christ-Crain, M. (2007) · BMC Infectious Diseases · doi:10.1186/1471-2334-7-10 · Cited by 411
Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study
Stolz, D., Smyrnios, N., Eggimann, P., Pargger, H., Thakkar, N., Siegemund, M., Marsch, S., Azzola, A., Rakic, J., Mueller, B., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00053209 · Cited by 327
Ubiquitous Expression of the Calcitonin-I Gene in Multiple Tissues in Response to Sepsis
Muller, B. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.396 · Cited by 324
Vogelmeier, C. F., Criner, G. J., Martínez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2017.02.001 · Cited by 309
The new antibiotic mantra-“shorter is better”.
Spellberg, B. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.3646 · Cited by 291
Procalcitonin Kinetics as a Prognostic Marker of Ventilator-associated Pneumonia
Luyt, C.-E., Guérin, V., Combes, A., Trouillet, J.-L., Ayed, S. B., Bernard, M., Gibert, C., & Chastre, J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200406-746oc · Cited by 288
Risk Prediction With Procalcitonin and Clinical Rules in Community-Acquired Pneumonia
Huang, D. T., Weissfeld, L. A., Kellum, J. A., Yealy, D. M., Kong, L., Martino, M., & Angus, D. C. (2008) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2008.01.003 · Cited by 213
Self-citationTonkin-Crine, S. K., Tan, P. S., van Hecke, O., Wang, K., Roberts, N. W., McCullough, A., Hansen, M. P., Butler, C. C., & Del Mar, C. B. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012252.pub2 · Cited by 213
Lindenauer, P. K. (2010) · JAMA · doi:10.1001/jama.2010.796 · Cited by 196
Uncomplicated Acute Bronchitis
Gonzales, R., & Sande, M. A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-12-200012190-00014 · Cited by 163
Have, T. R. T., Normand, S. T., Marcus, S. M., Brown, C. H., Lavori, P. W., & Duan, N. (2008) · Psychiatric Annals · doi:10.3928/00485713-20081201-10 · Cited by 146
Asthma health status measurement in clinical practice: validity of a new short and simple instrument
Barley, E. A., Quirk, F. H., & Jones, P. W. (1998) · Respiratory Medicine · doi:10.1016/s0954-6111(98)90423-1 · Cited by 142
Schüetz, P., Christ‐Crain, M., Wolbers, M., Schild, U., Thomann, R., Falconnier, C., Suter‐Widmer, I., Neidert, S., Blum, C. A., Schönenberger, R., et al. (2007) · BMC Health Services Research · doi:10.1186/1472-6963-7-102 · Cited by 127
Branche, A. R., Walsh, E. E., Vargas, R. L., Hulbert, B., Formica, M. A., Baran, A. M., Peterson, D. R., & Falsey, A. R. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv252 · Cited by 126
Jacobs, D. M., Noyes, K., Zhao, J., Gibson, W., Murphy, T. F., Sethi, S., & Ochs‐Balcom, H. M. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201712-913oc · Cited by 119
Hasegawa, K., Gibo, K., Tsugawa, Y., Shimada, Y. J., & Camargo, C. A. (2016) · CHEST Journal · doi:10.1016/j.chest.2015.12.039 · Cited by 52
Definitions of asthma exacerbations
Loymans, R. J. B., ter Riet, G., & Sterk, P. J. (2011) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3283466f45 · Cited by 39
Bang, H., & Davis, C. E. (2007) · Statistics in Medicine · doi:10.1002/sim.2663 · Cited by 35
Antibiotic Prescribing for Acute Respiratory Infections—Success That's Way Off the Mark
Linder, J. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1984 · Cited by 33
on behalf of the ProACT Investigators, Huang, D. T., Angus, D. C., Chang, C. H., Doi, Y., Fine, M. J., Kellum, J. A., Peck‐Palmer, O. M., Pike, F., Weissfeld, L. A., et al. (2017) · BMC Emergency Medicine · doi:10.1186/s12873-017-0138-1 · Cited by 13
Self-citationUsing the Instrumental Variables Estimator to Analyze Noninferiority Trials with Noncompliance
Kim, M. (2010) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543401003618157 · Cited by 12
Community‐acquired pneumonia: Defining quality care
Seymann, G. (2006) · Journal of Hospital Medicine · doi:10.1002/jhm.128 · Cited by 12
Procalcitonin and antibiotic therapy
Riedel, S. F. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318256b7da · Cited by 4
Cited by
Biomarkers of sepsis: time for a reappraisal
Pierrakos, C., Velissaris, D., Bisdorff, M., Marshall, J. C., & Vincent, J.-L. (2020) · Critical Care · doi:10.1186/s13054-020-02993-5 · Cited by 713
Schuetz, P., Beishuizen, A., Broyles, M., Ferrer, R., Gavazzi, G., Gluck, E. H., González del Castillo, J., Jensen, J.-U., Kanizsai, P. L., Kwa, A. L. H., et al. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-1181 · Cited by 279
Procalcitonin to Distinguish Viral From Bacterial Pneumonia: A Systematic Review and Meta-analysis
Kamat, I. S., Ramachandran, V., Eswaran, H., Guffey, D., & Musher, D. M. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz545 · Cited by 272
Rationalizing antimicrobial therapy in the ICU: a narrative review
Timsit, J.-F., Bassetti, M., Cremer, O., Daikos, G., de Waele, J., Kallil, A., Kipnis, E., Kollef, M., Laupland, K., Paiva, J.-A., et al. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05520-5 · Cited by 266
Point-of-care sensors for the management of sepsis
Reddy, B., Hassan, U., Seymour, C., Angus, D. C., Isbell, T. S., White, K., Weir, W., Yeh, L., Vincent, A., & Bashir, R. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0288-9 · Cited by 142
Self-citation
Metadata
- Authors
- Huang, D. T., Yealy, D. M., Filbin, M. R., Brown, A. M., Chang, C.-C. H., Doi, Y., Donnino, M. W., Fine, J., Fine, M. J., Fischer, M. A., Holst, J. M., Hou, P. C., Kellum, J. A., Khan, F., Kurz, M. C., Lotfipour, S., LoVecchio, F., Peck-Palmer, O. M., Pike, F., Prunty, H., Sherwin, R. L., Southerland, L., Terndrup, T., Weissfeld, L. A., Yabes, J., & Angus, D. C.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-07-19
- Volume
- 379
- Issue
- 3
- Pages
- 236-249
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2804105465
- Cited by
- 434
- References
- 45
- FWCI
- 33.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.